Reverse costimulation in the treatment of infectious diseases:
Saved in:
| Main Author: | |
|---|---|
| Format: | Electronic eBook |
| Language: | English |
| Published: |
New York
Nova Science Publishers
2014
|
| Series: | Allergies and infectious diseases
|
| Subjects: | |
| Item Description: | Print version record |
| Physical Description: | 1 online resource |
| ISBN: | 9781629482132 1629482137 |
Staff View
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044358086 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 170620s2014 |||| o||u| ||||||eng d | ||
| 020 | |a 9781629482132 |9 978-1-62948-213-2 | ||
| 020 | |a 1629482137 |9 1-62948-213-7 | ||
| 035 | |a (ZDB-4-NLEBK)ocn869544530 | ||
| 035 | |a (OCoLC)869544530 | ||
| 035 | |a (DE-599)BVBBV044358086 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 616.9706 |2 23 | |
| 100 | 1 | |a Mir, Manzoor Ahmad |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Reverse costimulation in the treatment of infectious diseases |c Manzoor Ahmad Mir |
| 264 | 1 | |a New York |b Nova Science Publishers |c 2014 | |
| 300 | |a 1 online resource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Allergies and infectious diseases | |
| 500 | |a Print version record | ||
| 505 | 8 | |a COSTIMULATION IMMUNOTHERAPY FOR AUTOIMMUNITY, TRANSPLANTATION AND LYMPHOMAS; COSTIMULATION IMMUNOTHERAPY FOR AUTOIMMUNITY, TRANSPLANTATION AND LYMPHOMAS; Library of Congress Cataloging-in-Publication Data; Dedicated to Our Beloved Mentor; Contents; Preface; Acknowledgment; About the Author; Chapter I Regulation of Immune System by Costimulatory Molecules; Abstract; Introduction; The B7 Family of Costimulatory Ligands; CD80 Costimulatory Molecule; CD86 Costimulatory Molecule; CD80 and CD86 Binding Kinetics to CD28 and CTLA-4; Different Oligomeric States of CD80 and CD86 | |
| 505 | 8 | |a CD80 and CD86 Expression KineticsRole of CD80/CD86 in Response to Bacterial Infection; PDL-1/B7-H1 Costimulatory Molecule; B7-H2/B7RP-1/Licos Costimulatory Molecule; B7-DC/PDL-2 Costimulatory Molecule; B7-H3 Costimulatory Molecule; B7-H4 or B7x/B7S1 Costimulatory Molecule; B7 Family of Receptors and Their Homologues; CD28 Molecule; Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Molecule; Reverse Costimulation through CTLA-4; ICOS (Inducible Costimulator Molecule); The Programmed Death-1 (PD-1); CD40 Costimulatory Molecule; CD40L/CD154 Costimulatory Molecule; CD40L/CD40 Interactions | |
| 505 | 8 | |a CD40-CD40-L Interactionin M. Tuberculosis InfectionConclusion; References; Chapter II Costimulatory Pathways in Transplantation Therapeutics; Abstract; Introduction; Transplantation Tolerance; Costimulatory Blockade and the Mixed Chimerism Approach; Clinical Translation of Costimulatory Blockade; Harnessing Negative Costimulatory Pathways; Costimulation As Therapeutic Approach for Graft VS Host Disease; CD28/ICOS/PD-1; Costimulatory in Models of Transplantation; CTLA-4 in Models of Transplantation; Belacept a Modified Version of CTLA4 in Kidney Transplantation | |
| 505 | 8 | |a PD-1: PD-L1/PD-L2 in Models of TransplantationPD-1 Pathway in Human Studies of Transplantation; B7-H3 in Models of Transplantation; B7-H4 in Models of Transplantation; BTLA in Models of Transplantation; Immunological Barriers to Effective Costimulation Blockade; Immunosuppressive Agents and Their Targets; Conclusion; References; Chapter III Costimulation in the Treatment of Autoimmune Diseases; Abstract; Introduction; Costimulation and Autoimmunity; CD28/CTLA4 and Their Ligands CD80/CD86; CD28 and B7 Families in Regulation of Autoimmunity; Co-Stimulatory Blockade in Human Autoimmune Diseases | |
| 505 | 8 | |a Alteration of B7/CD28/CTLA4 As Potential Therapy for AutoimmunityPotential Therapeutic Targets Associated with B7/CD28/CTLA-4; CD40-CD40 in Autoimmunity; CD40 and Autoimmune Thyroiditis; CD40 and Type 1 Diabetes (T1d); CD40 and Neuroinflammatory Diseases; CD40 and Rheumatoid Arthritis (RA); CD40 and Systemic Lupus Erythematosus (SLE); PD-1-PDL1 and PDL2 Pathways in Autoimmunity; CD44 Isoforms; Icos Pathways Regulate Autoimmunity; BTLA4-HVEM Pathway in Autoimmune Diseases; Regulatory T Cells in Autoimmunity; Conclusion; References; Chapter IV Costimulation in the Treatment of Lymphomas | |
| 505 | 8 | |a Cancer is one of the most prominent causes of mortality in children and adults causing about 9 million deaths annually, is a major health problem worldwide. The transformation of normal cells to cancer cells may arise due to dysregulation of oncogenes, tumor suppressors and/or stability genes. These transformed cells are sensed by the cells of the immune system, especially T cells, through specific receptors for an effective immune response. But unfortunately even after the interaction with T cells, an effective immune response is not generated. Considering the importance of costimulation in t | |
| 650 | 4 | |a Cellular therapy | |
| 650 | 4 | |a Immune System Diseases / therapy | |
| 650 | 4 | |a Immunologic diseases / Treatment | |
| 650 | 4 | |a Immunologic diseases | |
| 650 | 7 | |a HEALTH & FITNESS / Diseases / General |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Clinical Medicine |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Diseases |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Evidence-Based Medicine |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Internal Medicine |2 bisacsh | |
| 650 | 7 | |a Cellular therapy |2 fast | |
| 650 | 7 | |a Immunologic diseases / Treatment |2 fast | |
| 650 | 4 | |a Evidenz-basierte Medizin | |
| 650 | 4 | |a Innere Medizin | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Immunologic diseases |x Treatment |a Cellular therapy | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |a Mir, Manzoor Ahmad, author |t Reverse costimulation in the treatment of infectious diseases |z 9781628085198 |
| 912 | |a ZDB-4-NLEBK | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029760717 | ||
Record in the Search Index
| _version_ | 1804177603565715456 |
|---|---|
| any_adam_object | |
| author | Mir, Manzoor Ahmad |
| author_facet | Mir, Manzoor Ahmad |
| author_role | aut |
| author_sort | Mir, Manzoor Ahmad |
| author_variant | m a m ma mam |
| building | Verbundindex |
| bvnumber | BV044358086 |
| collection | ZDB-4-NLEBK |
| contents | COSTIMULATION IMMUNOTHERAPY FOR AUTOIMMUNITY, TRANSPLANTATION AND LYMPHOMAS; COSTIMULATION IMMUNOTHERAPY FOR AUTOIMMUNITY, TRANSPLANTATION AND LYMPHOMAS; Library of Congress Cataloging-in-Publication Data; Dedicated to Our Beloved Mentor; Contents; Preface; Acknowledgment; About the Author; Chapter I Regulation of Immune System by Costimulatory Molecules; Abstract; Introduction; The B7 Family of Costimulatory Ligands; CD80 Costimulatory Molecule; CD86 Costimulatory Molecule; CD80 and CD86 Binding Kinetics to CD28 and CTLA-4; Different Oligomeric States of CD80 and CD86 CD80 and CD86 Expression KineticsRole of CD80/CD86 in Response to Bacterial Infection; PDL-1/B7-H1 Costimulatory Molecule; B7-H2/B7RP-1/Licos Costimulatory Molecule; B7-DC/PDL-2 Costimulatory Molecule; B7-H3 Costimulatory Molecule; B7-H4 or B7x/B7S1 Costimulatory Molecule; B7 Family of Receptors and Their Homologues; CD28 Molecule; Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Molecule; Reverse Costimulation through CTLA-4; ICOS (Inducible Costimulator Molecule); The Programmed Death-1 (PD-1); CD40 Costimulatory Molecule; CD40L/CD154 Costimulatory Molecule; CD40L/CD40 Interactions CD40-CD40-L Interactionin M. Tuberculosis InfectionConclusion; References; Chapter II Costimulatory Pathways in Transplantation Therapeutics; Abstract; Introduction; Transplantation Tolerance; Costimulatory Blockade and the Mixed Chimerism Approach; Clinical Translation of Costimulatory Blockade; Harnessing Negative Costimulatory Pathways; Costimulation As Therapeutic Approach for Graft VS Host Disease; CD28/ICOS/PD-1; Costimulatory in Models of Transplantation; CTLA-4 in Models of Transplantation; Belacept a Modified Version of CTLA4 in Kidney Transplantation PD-1: PD-L1/PD-L2 in Models of TransplantationPD-1 Pathway in Human Studies of Transplantation; B7-H3 in Models of Transplantation; B7-H4 in Models of Transplantation; BTLA in Models of Transplantation; Immunological Barriers to Effective Costimulation Blockade; Immunosuppressive Agents and Their Targets; Conclusion; References; Chapter III Costimulation in the Treatment of Autoimmune Diseases; Abstract; Introduction; Costimulation and Autoimmunity; CD28/CTLA4 and Their Ligands CD80/CD86; CD28 and B7 Families in Regulation of Autoimmunity; Co-Stimulatory Blockade in Human Autoimmune Diseases Alteration of B7/CD28/CTLA4 As Potential Therapy for AutoimmunityPotential Therapeutic Targets Associated with B7/CD28/CTLA-4; CD40-CD40 in Autoimmunity; CD40 and Autoimmune Thyroiditis; CD40 and Type 1 Diabetes (T1d); CD40 and Neuroinflammatory Diseases; CD40 and Rheumatoid Arthritis (RA); CD40 and Systemic Lupus Erythematosus (SLE); PD-1-PDL1 and PDL2 Pathways in Autoimmunity; CD44 Isoforms; Icos Pathways Regulate Autoimmunity; BTLA4-HVEM Pathway in Autoimmune Diseases; Regulatory T Cells in Autoimmunity; Conclusion; References; Chapter IV Costimulation in the Treatment of Lymphomas Cancer is one of the most prominent causes of mortality in children and adults causing about 9 million deaths annually, is a major health problem worldwide. The transformation of normal cells to cancer cells may arise due to dysregulation of oncogenes, tumor suppressors and/or stability genes. These transformed cells are sensed by the cells of the immune system, especially T cells, through specific receptors for an effective immune response. But unfortunately even after the interaction with T cells, an effective immune response is not generated. Considering the importance of costimulation in t |
| ctrlnum | (ZDB-4-NLEBK)ocn869544530 (OCoLC)869544530 (DE-599)BVBBV044358086 |
| dewey-full | 616.9706 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.9706 |
| dewey-search | 616.9706 |
| dewey-sort | 3616.9706 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05429nmm a2200577zc 4500</leader><controlfield tag="001">BV044358086</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170620s2014 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781629482132</subfield><subfield code="9">978-1-62948-213-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1629482137</subfield><subfield code="9">1-62948-213-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-4-NLEBK)ocn869544530</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)869544530</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044358086</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.9706</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Mir, Manzoor Ahmad</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Reverse costimulation in the treatment of infectious diseases</subfield><subfield code="c">Manzoor Ahmad Mir</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Nova Science Publishers</subfield><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Allergies and infectious diseases</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Print version record</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">COSTIMULATION IMMUNOTHERAPY FOR AUTOIMMUNITY, TRANSPLANTATION AND LYMPHOMAS; COSTIMULATION IMMUNOTHERAPY FOR AUTOIMMUNITY, TRANSPLANTATION AND LYMPHOMAS; Library of Congress Cataloging-in-Publication Data; Dedicated to Our Beloved Mentor; Contents; Preface; Acknowledgment; About the Author; Chapter I Regulation of Immune System by Costimulatory Molecules; Abstract; Introduction; The B7 Family of Costimulatory Ligands; CD80 Costimulatory Molecule; CD86 Costimulatory Molecule; CD80 and CD86 Binding Kinetics to CD28 and CTLA-4; Different Oligomeric States of CD80 and CD86</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">CD80 and CD86 Expression KineticsRole of CD80/CD86 in Response to Bacterial Infection; PDL-1/B7-H1 Costimulatory Molecule; B7-H2/B7RP-1/Licos Costimulatory Molecule; B7-DC/PDL-2 Costimulatory Molecule; B7-H3 Costimulatory Molecule; B7-H4 or B7x/B7S1 Costimulatory Molecule; B7 Family of Receptors and Their Homologues; CD28 Molecule; Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Molecule; Reverse Costimulation through CTLA-4; ICOS (Inducible Costimulator Molecule); The Programmed Death-1 (PD-1); CD40 Costimulatory Molecule; CD40L/CD154 Costimulatory Molecule; CD40L/CD40 Interactions</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">CD40-CD40-L Interactionin M. Tuberculosis InfectionConclusion; References; Chapter II Costimulatory Pathways in Transplantation Therapeutics; Abstract; Introduction; Transplantation Tolerance; Costimulatory Blockade and the Mixed Chimerism Approach; Clinical Translation of Costimulatory Blockade; Harnessing Negative Costimulatory Pathways; Costimulation As Therapeutic Approach for Graft VS Host Disease; CD28/ICOS/PD-1; Costimulatory in Models of Transplantation; CTLA-4 in Models of Transplantation; Belacept a Modified Version of CTLA4 in Kidney Transplantation</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">PD-1: PD-L1/PD-L2 in Models of TransplantationPD-1 Pathway in Human Studies of Transplantation; B7-H3 in Models of Transplantation; B7-H4 in Models of Transplantation; BTLA in Models of Transplantation; Immunological Barriers to Effective Costimulation Blockade; Immunosuppressive Agents and Their Targets; Conclusion; References; Chapter III Costimulation in the Treatment of Autoimmune Diseases; Abstract; Introduction; Costimulation and Autoimmunity; CD28/CTLA4 and Their Ligands CD80/CD86; CD28 and B7 Families in Regulation of Autoimmunity; Co-Stimulatory Blockade in Human Autoimmune Diseases</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Alteration of B7/CD28/CTLA4 As Potential Therapy for AutoimmunityPotential Therapeutic Targets Associated with B7/CD28/CTLA-4; CD40-CD40 in Autoimmunity; CD40 and Autoimmune Thyroiditis; CD40 and Type 1 Diabetes (T1d); CD40 and Neuroinflammatory Diseases; CD40 and Rheumatoid Arthritis (RA); CD40 and Systemic Lupus Erythematosus (SLE); PD-1-PDL1 and PDL2 Pathways in Autoimmunity; CD44 Isoforms; Icos Pathways Regulate Autoimmunity; BTLA4-HVEM Pathway in Autoimmune Diseases; Regulatory T Cells in Autoimmunity; Conclusion; References; Chapter IV Costimulation in the Treatment of Lymphomas</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Cancer is one of the most prominent causes of mortality in children and adults causing about 9 million deaths annually, is a major health problem worldwide. The transformation of normal cells to cancer cells may arise due to dysregulation of oncogenes, tumor suppressors and/or stability genes. These transformed cells are sensed by the cells of the immune system, especially T cells, through specific receptors for an effective immune response. But unfortunately even after the interaction with T cells, an effective immune response is not generated. Considering the importance of costimulation in t</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cellular therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immune System Diseases / therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunologic diseases / Treatment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunologic diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / General</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Clinical Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Diseases</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Evidence-Based Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Internal Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cellular therapy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immunologic diseases / Treatment</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Evidenz-basierte Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Innere Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunologic diseases</subfield><subfield code="x">Treatment</subfield><subfield code="a">Cellular therapy</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="a">Mir, Manzoor Ahmad, author</subfield><subfield code="t">Reverse costimulation in the treatment of infectious diseases</subfield><subfield code="z">9781628085198</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-NLEBK</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029760717</subfield></datafield></record></collection> |
| id | DE-604.BV044358086 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:50:42Z |
| institution | BVB |
| isbn | 9781629482132 1629482137 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029760717 |
| oclc_num | 869544530 |
| open_access_boolean | |
| physical | 1 online resource |
| psigel | ZDB-4-NLEBK |
| publishDate | 2014 |
| publishDateSearch | 2014 |
| publishDateSort | 2014 |
| publisher | Nova Science Publishers |
| record_format | marc |
| series2 | Allergies and infectious diseases |
| spelling | Mir, Manzoor Ahmad Verfasser aut Reverse costimulation in the treatment of infectious diseases Manzoor Ahmad Mir New York Nova Science Publishers 2014 1 online resource txt rdacontent c rdamedia cr rdacarrier Allergies and infectious diseases Print version record COSTIMULATION IMMUNOTHERAPY FOR AUTOIMMUNITY, TRANSPLANTATION AND LYMPHOMAS; COSTIMULATION IMMUNOTHERAPY FOR AUTOIMMUNITY, TRANSPLANTATION AND LYMPHOMAS; Library of Congress Cataloging-in-Publication Data; Dedicated to Our Beloved Mentor; Contents; Preface; Acknowledgment; About the Author; Chapter I Regulation of Immune System by Costimulatory Molecules; Abstract; Introduction; The B7 Family of Costimulatory Ligands; CD80 Costimulatory Molecule; CD86 Costimulatory Molecule; CD80 and CD86 Binding Kinetics to CD28 and CTLA-4; Different Oligomeric States of CD80 and CD86 CD80 and CD86 Expression KineticsRole of CD80/CD86 in Response to Bacterial Infection; PDL-1/B7-H1 Costimulatory Molecule; B7-H2/B7RP-1/Licos Costimulatory Molecule; B7-DC/PDL-2 Costimulatory Molecule; B7-H3 Costimulatory Molecule; B7-H4 or B7x/B7S1 Costimulatory Molecule; B7 Family of Receptors and Their Homologues; CD28 Molecule; Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Molecule; Reverse Costimulation through CTLA-4; ICOS (Inducible Costimulator Molecule); The Programmed Death-1 (PD-1); CD40 Costimulatory Molecule; CD40L/CD154 Costimulatory Molecule; CD40L/CD40 Interactions CD40-CD40-L Interactionin M. Tuberculosis InfectionConclusion; References; Chapter II Costimulatory Pathways in Transplantation Therapeutics; Abstract; Introduction; Transplantation Tolerance; Costimulatory Blockade and the Mixed Chimerism Approach; Clinical Translation of Costimulatory Blockade; Harnessing Negative Costimulatory Pathways; Costimulation As Therapeutic Approach for Graft VS Host Disease; CD28/ICOS/PD-1; Costimulatory in Models of Transplantation; CTLA-4 in Models of Transplantation; Belacept a Modified Version of CTLA4 in Kidney Transplantation PD-1: PD-L1/PD-L2 in Models of TransplantationPD-1 Pathway in Human Studies of Transplantation; B7-H3 in Models of Transplantation; B7-H4 in Models of Transplantation; BTLA in Models of Transplantation; Immunological Barriers to Effective Costimulation Blockade; Immunosuppressive Agents and Their Targets; Conclusion; References; Chapter III Costimulation in the Treatment of Autoimmune Diseases; Abstract; Introduction; Costimulation and Autoimmunity; CD28/CTLA4 and Their Ligands CD80/CD86; CD28 and B7 Families in Regulation of Autoimmunity; Co-Stimulatory Blockade in Human Autoimmune Diseases Alteration of B7/CD28/CTLA4 As Potential Therapy for AutoimmunityPotential Therapeutic Targets Associated with B7/CD28/CTLA-4; CD40-CD40 in Autoimmunity; CD40 and Autoimmune Thyroiditis; CD40 and Type 1 Diabetes (T1d); CD40 and Neuroinflammatory Diseases; CD40 and Rheumatoid Arthritis (RA); CD40 and Systemic Lupus Erythematosus (SLE); PD-1-PDL1 and PDL2 Pathways in Autoimmunity; CD44 Isoforms; Icos Pathways Regulate Autoimmunity; BTLA4-HVEM Pathway in Autoimmune Diseases; Regulatory T Cells in Autoimmunity; Conclusion; References; Chapter IV Costimulation in the Treatment of Lymphomas Cancer is one of the most prominent causes of mortality in children and adults causing about 9 million deaths annually, is a major health problem worldwide. The transformation of normal cells to cancer cells may arise due to dysregulation of oncogenes, tumor suppressors and/or stability genes. These transformed cells are sensed by the cells of the immune system, especially T cells, through specific receptors for an effective immune response. But unfortunately even after the interaction with T cells, an effective immune response is not generated. Considering the importance of costimulation in t Cellular therapy Immune System Diseases / therapy Immunologic diseases / Treatment Immunologic diseases HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Cellular therapy fast Immunologic diseases / Treatment fast Evidenz-basierte Medizin Innere Medizin Medizin Immunologic diseases Treatment Cellular therapy Erscheint auch als Druck-Ausgabe Mir, Manzoor Ahmad, author Reverse costimulation in the treatment of infectious diseases 9781628085198 |
| spellingShingle | Mir, Manzoor Ahmad Reverse costimulation in the treatment of infectious diseases COSTIMULATION IMMUNOTHERAPY FOR AUTOIMMUNITY, TRANSPLANTATION AND LYMPHOMAS; COSTIMULATION IMMUNOTHERAPY FOR AUTOIMMUNITY, TRANSPLANTATION AND LYMPHOMAS; Library of Congress Cataloging-in-Publication Data; Dedicated to Our Beloved Mentor; Contents; Preface; Acknowledgment; About the Author; Chapter I Regulation of Immune System by Costimulatory Molecules; Abstract; Introduction; The B7 Family of Costimulatory Ligands; CD80 Costimulatory Molecule; CD86 Costimulatory Molecule; CD80 and CD86 Binding Kinetics to CD28 and CTLA-4; Different Oligomeric States of CD80 and CD86 CD80 and CD86 Expression KineticsRole of CD80/CD86 in Response to Bacterial Infection; PDL-1/B7-H1 Costimulatory Molecule; B7-H2/B7RP-1/Licos Costimulatory Molecule; B7-DC/PDL-2 Costimulatory Molecule; B7-H3 Costimulatory Molecule; B7-H4 or B7x/B7S1 Costimulatory Molecule; B7 Family of Receptors and Their Homologues; CD28 Molecule; Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Molecule; Reverse Costimulation through CTLA-4; ICOS (Inducible Costimulator Molecule); The Programmed Death-1 (PD-1); CD40 Costimulatory Molecule; CD40L/CD154 Costimulatory Molecule; CD40L/CD40 Interactions CD40-CD40-L Interactionin M. Tuberculosis InfectionConclusion; References; Chapter II Costimulatory Pathways in Transplantation Therapeutics; Abstract; Introduction; Transplantation Tolerance; Costimulatory Blockade and the Mixed Chimerism Approach; Clinical Translation of Costimulatory Blockade; Harnessing Negative Costimulatory Pathways; Costimulation As Therapeutic Approach for Graft VS Host Disease; CD28/ICOS/PD-1; Costimulatory in Models of Transplantation; CTLA-4 in Models of Transplantation; Belacept a Modified Version of CTLA4 in Kidney Transplantation PD-1: PD-L1/PD-L2 in Models of TransplantationPD-1 Pathway in Human Studies of Transplantation; B7-H3 in Models of Transplantation; B7-H4 in Models of Transplantation; BTLA in Models of Transplantation; Immunological Barriers to Effective Costimulation Blockade; Immunosuppressive Agents and Their Targets; Conclusion; References; Chapter III Costimulation in the Treatment of Autoimmune Diseases; Abstract; Introduction; Costimulation and Autoimmunity; CD28/CTLA4 and Their Ligands CD80/CD86; CD28 and B7 Families in Regulation of Autoimmunity; Co-Stimulatory Blockade in Human Autoimmune Diseases Alteration of B7/CD28/CTLA4 As Potential Therapy for AutoimmunityPotential Therapeutic Targets Associated with B7/CD28/CTLA-4; CD40-CD40 in Autoimmunity; CD40 and Autoimmune Thyroiditis; CD40 and Type 1 Diabetes (T1d); CD40 and Neuroinflammatory Diseases; CD40 and Rheumatoid Arthritis (RA); CD40 and Systemic Lupus Erythematosus (SLE); PD-1-PDL1 and PDL2 Pathways in Autoimmunity; CD44 Isoforms; Icos Pathways Regulate Autoimmunity; BTLA4-HVEM Pathway in Autoimmune Diseases; Regulatory T Cells in Autoimmunity; Conclusion; References; Chapter IV Costimulation in the Treatment of Lymphomas Cancer is one of the most prominent causes of mortality in children and adults causing about 9 million deaths annually, is a major health problem worldwide. The transformation of normal cells to cancer cells may arise due to dysregulation of oncogenes, tumor suppressors and/or stability genes. These transformed cells are sensed by the cells of the immune system, especially T cells, through specific receptors for an effective immune response. But unfortunately even after the interaction with T cells, an effective immune response is not generated. Considering the importance of costimulation in t Cellular therapy Immune System Diseases / therapy Immunologic diseases / Treatment Immunologic diseases HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Cellular therapy fast Immunologic diseases / Treatment fast Evidenz-basierte Medizin Innere Medizin Medizin Immunologic diseases Treatment Cellular therapy |
| title | Reverse costimulation in the treatment of infectious diseases |
| title_auth | Reverse costimulation in the treatment of infectious diseases |
| title_exact_search | Reverse costimulation in the treatment of infectious diseases |
| title_full | Reverse costimulation in the treatment of infectious diseases Manzoor Ahmad Mir |
| title_fullStr | Reverse costimulation in the treatment of infectious diseases Manzoor Ahmad Mir |
| title_full_unstemmed | Reverse costimulation in the treatment of infectious diseases Manzoor Ahmad Mir |
| title_short | Reverse costimulation in the treatment of infectious diseases |
| title_sort | reverse costimulation in the treatment of infectious diseases |
| topic | Cellular therapy Immune System Diseases / therapy Immunologic diseases / Treatment Immunologic diseases HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Cellular therapy fast Immunologic diseases / Treatment fast Evidenz-basierte Medizin Innere Medizin Medizin Immunologic diseases Treatment Cellular therapy |
| topic_facet | Cellular therapy Immune System Diseases / therapy Immunologic diseases / Treatment Immunologic diseases HEALTH & FITNESS / Diseases / General MEDICAL / Clinical Medicine MEDICAL / Diseases MEDICAL / Evidence-Based Medicine MEDICAL / Internal Medicine Evidenz-basierte Medizin Innere Medizin Medizin Immunologic diseases Treatment Cellular therapy |
| work_keys_str_mv | AT mirmanzoorahmad reversecostimulationinthetreatmentofinfectiousdiseases |